Roche’s Evrysdi continues to improve motor function and survival in babies with Type 1 Spinal Muscular Atrophy (SMA)

NEXT STORY
Sitryx further strengthens leadership team with the appointment of Iain Kilty, Ph.D., as Chief Scientific Officer
PREV STORY
California Water Service Group Announces Nomination of Dr. Yvonne A. Maldonado for Election to Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PreCheck Health Services, Inc. appoints Dr. Mitch Ghen as its Chief Science Officer

author_avatar
NASDAQ Market News

ETFO members’ survey shows violence pervasive in schools

Toronto, ON, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Seventy per cent of members of ...

author_avatar
NASDAQ Market News

NeuroMetrix Reports Q4 and Full Year 2017 Financial Results

WALTHAM, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), today reported financial ...

author_avatar
NASDAQ Market News